BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12670496)

  • 1. In vitro assessment of inhibition by natural polyphenols of metabolic activation of procarcinogens by human CYP1A1.
    Schwarz D; Roots I
    Biochem Biophys Res Commun; 2003 Apr; 303(3):902-7. PubMed ID: 12670496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450.
    Muto S; Fujita K; Yamazaki Y; Kamataki T
    Mutat Res; 2001 Aug; 479(1-2):197-206. PubMed ID: 11470492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. St. John's wort extracts and some of their constituents potently inhibit ultimate carcinogen formation from benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1.
    Schwarz D; Kisselev P; Roots I
    Cancer Res; 2003 Nov; 63(22):8062-8. PubMed ID: 14633740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential inhibition of human cytochrome P450 enzymes by epsilon-viniferin, the dimer of resveratrol: comparison with resveratrol and polyphenols from alcoholized beverages.
    Piver B; Berthou F; Dreano Y; Lucas D
    Life Sci; 2003 Jul; 73(9):1199-213. PubMed ID: 12818727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol is a selective human cytochrome P450 1A1 inhibitor.
    Chun YJ; Kim MY; Guengerich FP
    Biochem Biophys Res Commun; 1999 Aug; 262(1):20-4. PubMed ID: 10448061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol.
    Ciolino HP; Yeh GC
    Mol Pharmacol; 1999 Oct; 56(4):760-7. PubMed ID: 10496959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of 17β-estradiol activation by CYP1A1: genotype- and regioselective inhibition by St. John's Wort and several natural polyphenols.
    Schwarz D; Kisselev P; Schunck WH; Roots I
    Biochim Biophys Acta; 2011 Jan; 1814(1):168-74. PubMed ID: 20883830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of benzo[a]pyrene-activating enzymes and DNA binding in human bronchial epithelial BEAS-2B cells by methoxylated flavonoids.
    Tsuji PA; Walle T
    Carcinogenesis; 2006 Aug; 27(8):1579-85. PubMed ID: 16484233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1 variants.
    Schwarz D; Kisselev P; Cascorbi I; Schunck WH; Roots I
    Carcinogenesis; 2001 Mar; 22(3):453-9. PubMed ID: 11238186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential induction of CYP1B1 by benzo[a]pyrene in human oral epithelial cells: impact on DNA adduct formation and prevention by polyphenols.
    Wen X; Walle T
    Carcinogenesis; 2005 Oct; 26(10):1774-81. PubMed ID: 15905203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human cytochrome P450 1A1-, 1A2-, and 1B1-mediated activation of procarcinogens to genotoxic metabolites by polycyclic aromatic hydrocarbons.
    Shimada T; Guengerich FP
    Chem Res Toxicol; 2006 Feb; 19(2):288-94. PubMed ID: 16485905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of inhibition of CYP1A1 and glutathione S-transferase activities in fish liver by quercetin, resveratrol, naringenin, hesperidin, and rutin.
    Arinç E; Yilmaz D; Bozcaarmutlu A
    Nutr Cancer; 2015; 67(1):137-44. PubMed ID: 25372667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The alkaloid rutaecarpine is a selective inhibitor of cytochrome P450 1A in mouse and human liver microsomes.
    Ueng YF; Jan WC; Lin LC; Chen TL; Guengerich FP; Chen CF
    Drug Metab Dispos; 2002 Mar; 30(3):349-53. PubMed ID: 11854157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP1A1 genotype-selective inhibition of benzo[a]pyrene activation by quercetin.
    Schwarz D; Kisselev P; Roots I
    Eur J Cancer; 2005 Jan; 41(1):151-8. PubMed ID: 15618000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing a high-throughput system for the screening of cytochrome P450 1A1--inhibitory polyphenols.
    Leung HY; Wang Y; Chan HY; Leung LK
    Toxicol In Vitro; 2007 Sep; 21(6):996-1002. PubMed ID: 17560072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of resveratrol-salicylate hybrid derivatives as CYP1A1 inhibitors.
    Aldawsari FS; Elshenawy OH; El Gendy MA; Aguayo-Ortiz R; Baksh S; El-Kadi AO; Velázquez-Martínez CA
    J Enzyme Inhib Med Chem; 2015 Dec; 30(6):884-95. PubMed ID: 25407017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flavonoids inhibit genetic toxicity produced by carcinogens in cells expressing CYP1A2 and CYP1A1.
    Lautraite S; Musonda AC; Doehmer J; Edwards GO; Chipman JK
    Mutagenesis; 2002 Jan; 17(1):45-53. PubMed ID: 11752233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Black tea polyphenols, theaflavins, prevent cellular DNA damage by inhibiting oxidative stress and suppressing cytochrome P450 1A1 in cell cultures.
    Feng Q; Torii Y; Uchida K; Nakamura Y; Hara Y; Osawa T
    J Agric Food Chem; 2002 Jan; 50(1):213-20. PubMed ID: 11754570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of
    Delgado-Roche L; Santes-Palacios R; Herrera JA; Hernández SL; Riera M; Fernández MD; Mesta F; Garrido G; Rodeiro I; Espinosa-Aguirre JJ
    Mar Drugs; 2020 Nov; 18(11):. PubMed ID: 33227946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism-based inhibition of human cytochrome P450 1A1 by rhapontigenin.
    Chun YJ; Ryu SY; Jeong TC; Kim MY
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):389-93. PubMed ID: 11259321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.